U.S. health authorities study available data on cases of potentially serious side effects among people who have received the vaccine Johnson & Johnson for the new coronavirus, in addition to those that have already led to the suspension of its use, said yesterday Rosell Wallinski, director of the Centers for Disease Control and Prevention (CDC), reports APE.
Last week, U.S. regulators called for a halt to J&J product delivery due to severe blood clots in six women under the age of 50 who were among the 7 million people who received the vaccine, given one dose.
“It encourages us that there have not been a large number of cases, but we are looking at it, studying (the reports) we have,” Ms Wallinski told a news conference yesterday.
The Federal Drug Administration (FDA) is monitoring the US government’s database of additional side effects, he added.
Rosell Wallinski did not elaborate on the nature of the side effects, other than blood clots.
A CDC Advisory Committee will meet on Friday to review the data on possible serious side effects of the J&J product and to give an opinion on whether its use should be continued as part of the immunization campaign. Experts expect it to start again, but once there are clear guidelines for diagnosing and treating thrombosis, a potential side effect.
The increase in J&J vaccine dose production may be slower than originally anticipated. The FDA last month postponed licensing a plant that will produce large quantities of the product, following errors that destroyed millions of doses.
The White House’s adviser on tackling the new coronavirus, Andy Slavit, reassured Americans yesterday that the country had plenty of vaccines and that immunization “has never been easier” for them. Some three million doses of Pfizer Inc / BioNTech and Moderna vaccines are given to citizens daily (both in two doses).
Rich governments are considering getting Pfizer / BioNTech and Moderna vaccines to meet their immunization campaign timetables amid concerns about the side effects of J&J and AstraZeneca.
Some 260 million doses of the vaccine have been distributed in the United States, of which about 210 million have already been administered, according to CDC data as of Sunday.
According to the CDC director, of the 84 million people who have been fully immunized in the United States, fewer than 6,000 developed symptoms of COVID-19 two weeks or more after receiving their second dose. Nearly 400 of them were hospitalized and about 75 died, according to CDC data. However, some of the hospital admissions and some of the deaths were not due to COVID-19.
“It simply came to our notice then. “These vaccines are effective,” she said.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
